Lanean...
The cost effectiveness of ivabradine in the treatment of chronic heart failure from the UK National Health Service perspective
OBJECTIVE: Ivabradine, a specific heart rate lowering therapy, has been shown in a randomised placebo-controlled study, Systolic HF Treatment with the I(f) Inhibitor Ivabradine Trial (SHI(f)T), to significantly reduce the composite end point of cardiovascular death and hospitalisation for worsening...
Gorde:
| Egile Nagusiak: | , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMJ Publishing Group
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4078716/ https://ncbi.nlm.nih.gov/pubmed/24634022 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/heartjnl-2013-304598 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|